BioHarvest Sciences Inc.
8MV0.F
1.41 EUR
1 Tag: -8.44% (-0.13 EUR)
Der Alarm wird direkt gespeichert, ohne auf die Homepage zu springen.
Kursalarme fuer 8MV0.F
Bitte anmelden, um Kursalarme zu sehen und zu speichern.
Finanzen
Unternehmensinfo
BioHarvest Sciences Inc. operates as a biotechnology company in Israel and the United States. It operates through two segments: Products and CDMO Services. The company develops botanical synthesis platform technology to produce plant cells with higher concentrations of active ingredients. It is involved in the research, development, manufacturing, marketing, and sale of science-based health and wellness nutraceutical solutions that are manufactured and sold as dietary supplements and functional food and beverages, as well as the manufacturing, marketing, and sale of science-based health, pharmaceutical, and cosmeceutical solutions. The company also provides contract development and manufacturing operation services. Further, it offers VINIA, a red grape cell dietary supplement containing the matrix of polyphenols contained in red wine. The company has a strategic collaboration with Tate & Lyle plc for the development of plant-based sweetener molecules. The company is based in Vancouver, Canada.
Aktuelle News
-
BioHarvest Sciences to Participate in the "Health, Wellness & Longevity" Virtual Conference Presented by Maxim Group LLC
Vorschau anzeigen
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 13, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held virtually on July 22, 2026.Presentation Details:Date/Time: Wednesday, July 22, 2026 at 10:00 a.m...
-
BioHarvest Sciences to Present at the 2026 BIO International Convention
Vorschau anzeigen
Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - June 18, 2026) - BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details:Session: Company PresentationDate/Time: Wednesday, June 24, 11:45 AMLocation: Theater 3BioHarvest Sciences'...
-
BioHarvest Sciences (BHST) Q2 2026 Earnings Call Transcript
Vorschau anzeigen
Rakib outlines shift toward CDMO and secures $20M-$30M fragrance contract.
-
BioHarvest Sciences Inc (BHST) (Q2 2026) Earnings Call Highlights: Strategic Pivot to ...
Vorschau anzeigen
BioHarvest Sciences Inc (BHST) secures landmark fragrance CDMO deal and narrows EBITDA loss guidance despite D2C headwinds.
-
BioHarvest Sciences Inc. Common Stock Q2 2026 Earnings Call Summary
Vorschau anzeigen
Moby summary of BioHarvest Sciences Inc. Common Stock's Q2 2026 earnings call